CollPlant Biotechnologies
CLGN
15 hedge funds and large institutions have $582K invested in CollPlant Biotechnologies in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 6 closing their positions.
0.1% more ownership
Funds ownership: 1.06% → 1.16% (+0.1%)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
25% less funds holding
Funds holding: 20 → 15 (-5)
29% less capital invested
Capital invested by funds: $819K → $582K (-$237K)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Pinnacle Associates
New York
|
+$69.9K |
| 2 |
Renaissance Technologies
New York
|
+$17.2K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$8.29K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$362 |
| 5 |
SFG
Strive Financial Group
Carmel,
Indiana
|
+$65 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$34.3K |
| 2 |
VF
Virtu Financial
New York
|
-$7K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$6.09K |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
-$5.39K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$749 |
CLGN Hedge Fund Activity: Q2 2026 in Review
15 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q2 2026, worth a combined $582K — down 29% from $819K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CLGN and 1 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 4 added.
The largest buyer was Pinnacle Associates, adding an estimated $69.9K. The largest seller was Armistice Capital, exiting entirely with an estimated $34.3K sold.
- 15 institutional investors held CollPlant Biotechnologies (CLGN) as of Q2 2026, down from 20 in Q1 2026.
- Funds reported $582K of CollPlant Biotechnologies stock for Q2 2026, down 29% quarter-over-quarter.
- 1 fund opened new CollPlant Biotechnologies positions in Q2 2026 and 6 closed out, a net change of -5 holders.
- The largest CollPlant Biotechnologies buyer in Q2 2026 was Pinnacle Associates, an estimated $69.9K added.
- The largest CollPlant Biotechnologies seller in Q2 2026 was Armistice Capital, an estimated $34.3K sold.
Based on aggregated 13F filings for Q2 2026.